Cargando…
Drug-induced CD30+ Skin Lesions: Complex Interplay Between Infectious Agents, Human Leukocyte Antigen System and Mast Cells/T Cells
Autor principal: | Khan, Sujoy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966408/ https://www.ncbi.nlm.nih.gov/pubmed/27512195 http://dx.doi.org/10.4103/0019-5154.185721 |
Ejemplares similares
-
Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30(+) lymphoma patients
por: Wang, D., et al.
Publicado: (2020) -
Leukocyte common antigen (CD45) is required for immunoglobulin E- mediated degranulation of mast cells
Publicado: (1994) -
The importance of mast cells in interstitial cystitis/bladder pain syndrome
por: Ratner, Vicki
Publicado: (2016) -
HLA-DR(+) leukocytes acquire CD1 antigens in embryonic and fetal human skin and contain functional antigen-presenting cells
por: Schuster, Christopher, et al.
Publicado: (2009) -
Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
por: Huo, Yu-Jia, et al.
Publicado: (2022)